Sulindac does not preserve renal prostacyclin synthesis during endotoxemiaOLANOFF, L. S; COOK, J. A; HALUSHKA, P. V et al.Prostaglandins. 1985, Vol 29, Num 6, pp 1031-1037, issn 0090-6980Article

Comparison of gastric and intestinal antisecretory and protective effects of prostacyclin and its stable thia-imino-analogue (Hoe 892) in conscious ratsKONTUREK, S. J; BRZOZOWSKI, T; RADECKI, T et al.Prostaglandins. 1984, Vol 28, Num 4, pp 443-453, issn 0090-6980Article

UTILIZATION OF HUMAN SERUM ALBUMIN AS DRUG ADDITIVES. I: STABILIZER OF PROSTACYCLINKURONO Y; OHTA N; IKEDA K et al.1982; CHEMICAL AND PHARMACEUTICAL BULLETIN; ISSN 0009-2363; JPN; DA. 1982; VOL. 30; NO 7; PP. 2635-2638; BIBL. 12 REF.Article

Pharmacokinetics and pharmacodynamics of the stable prostacyclin analogue, ZK 36 374, in the catKRAUSE, W; BECKMANN, R; SCHUBERT, M et al.Prostaglandins leukotrienes and medicine. 1984, Vol 15, Num 2, pp 187-197, issn 0262-1746Article

Bioassay-Abenteuer auf dem Weg zum Prostacyclin (Nobel-Vortrag) = Aventures sur la voie du dosage de la Prostaglandine I2 (Conférence Nobel) = Story of the advances on bioassay of prostaglandin I2 (Nobel conference)VANE, J. R.Angewandte Chemie. 1983, Vol 95, Num 10, pp 782-794, issn 0044-8249Article

PROSTACYCLIN IN CARDIOPULMONARY BYPASS OPERATIONSFAICHNEY A; DAVIDSON KG; WHEATLEY DJ et al.1982; J. THORAC. CARDIOVASC. SURG.; ISSN 0022-5223; USA; DA. 1982; VOL. 84; NO 4; PP. 601-608; BIBL. 23 REF.Article

Suppression of vascular prostacyclin generation by jaundiced serum: relation to lipid peroxidesSCHROEDER, E. T; FINN, A. F. JR; HUEBER, P et al.The Journal of laboratory and clinical medicine. 1988, Vol 112, Num 6, pp 784-791, issn 0022-2143Article

Prostacyclin therapy during cardiopulmonary bypass-is it beneficial?TAYLOR, K. M.Perfusion. 1987, Vol 2, Num 1, pp 1-7Article

Enkephalins modify granulocyte-endothelial interactions by stimulating prostacyclin productionBOOGAERTS, M. A; VERMYLEN, J; DECKMYN, H et al.Thrombosis and haemostasis. 1983, Vol 50, Num 2, pp 572-575, issn 0340-6245Article

PROSTACYCLINWEKSLER BB.1982; PROGRESS IN HEMOSTASIS AND THROMBOSIS; ISSN 0362-6350; USA; DA. 1982; VOL. 6; PP. 113-138; BIBL. 246 REF.Article

PLATELET LABELING WITH IN-111 OXINE: BENEFIT OF PROSTACYCLIN (PGL₂) - ADDITION FOR PREPARATION AND INJECTION. REPLYSINZINGER H; ANGELBERGER P; HOEFER R et al.1981; J. NUCL. MED.; ISSN 0022-3123; USA; DA. 1981; VOL. 22; NO 3; PP. 292-393; BIBL. 2 REF.Article

STABILITY OF PROSTACYCLIN IN HUMAN PLASMA AND WHOLE BLOOD: STUDIES ON THE PROTECTIVE EFFECT OF ALBUMINORCHARD MA; ROBINSON C.1981; THROMB. HAEMOST.; ISSN 0340-6245; DEU; DA. 1981; VOL. 46; NO 3; PP. 645-647; BIBL. 23 REF.Article

METABOLISM OF PROSTACYCLIN BY 9-HYDROXYPROSTAGLANDIN DEHYDROGENASE IN HUMAN PLATELETSWONG PYK; LEE WH; CHAO PHW et al.1980; J. BIOL. CHEM.; ISSN 0021-9258; USA; DA. 1980; VOL. 255; NO 19; PP. 9021-9024; BIBL. 24 REF.Article

ON THE OCCURRENCE OF PROSTACYCLIN METABOLITES IN PLASMA AND VASCULAR TISSUE AS DETERMINED RADIOIMMUNOLOGICALLYPESKAR BM; WEILER H; SCHMIDBERGER P et al.1980; FEBS LETT.; ISSN 0014-5793; NLD; DA. 1980; VOL. 121; NO 1; PP. 25-28; BIBL. 20 REF.Article

Modulation of prostacyclin biosynthesis by calcium entry blockers and extracellular calciumVAN DE VELDE, V. J. S; VAN DEN BOSSCHE, R. M; BULT, H et al.Biochemical pharmacology. 1986, Vol 35, Num 2, pp 253-256, issn 0006-2952Article

Relative insensitivity of epinephrine induced platelet aggregation to prostacyclinZAHAVI, M; ZAHAVI, J.Thrombosis research. 1986, Vol 44, Num 1, pp 119-124, issn 0049-3848Article

Mechanism of cyclosporin A-induced inhibition of prostacyclin synthesis by macrophagesFAN, T.-P. D; LEWIS, G. P.Prostaglandins. 1985, Vol 30, Num 5, pp 735-747, issn 0090-6980Article

The effect of prostacyclin infusion on platelet hemostatic function in patients undergoing cardiopulmonary bypassMALPASS, T. W; AMORY, D. W; HARKER, L. A et al.Journal of thoracic and cardiovascular surgery. 1984, Vol 87, Num 4, pp 550-555, issn 0022-5223Article

CIGARETTE SMOKING INHIBITS PROSTACYCLIN FORMATIONNADLER JL; VELASCO J; HORTON R et al.1983; LANCET (THE) (BRITISH EDITION); ISSN 0140-6736; GBR; DA. 1983; NO 8336; PP. 1248-1250; BIBL. 22 REF.Article

The effects of prostacyclin on the coagulation of whole bloodHOLLOWAY, D. S; ZUCKERMAN, L; VAGHER, J. P et al.Thrombosis and haemostasis. 1983, Vol 50, Num 3, pp 671-675, issn 0340-6245Article

A prospective study of the clinical benefits of prostacyclin in 554 cardiopulmonary bypass proceduresMERLI, M; AMARI, B; CARTANI, C et al.Texas Heart Institute journal. 1988, Vol 15, Num 2, pp 86-90, issn 0730-2347Article

Quantitation of serum prostacyclin-binding in thrombotic thrombocytopenic purpuraAH-LIM TSAI; MANNER, C. E; RUDERSDORF, T et al.Thrombosis research. 1988, Vol 51, Num 6, pp 583-592, issn 0049-3848Article

Anti-shock properties of the prostacyclin analog, iloprost, in traumatic shockLEVITT, M. A; LEFER, A. M.Prostaglandins leukotrienes and medicine. 1986, Vol 25, Num 2-3, pp 175-185, issn 0262-1746Article

Prostacyclin acts in rat gastric (fundic) mucosa via the intracellular second messenger systemBALINT, G. A; VARRO, V.Collection sécurité. 1985, Vol 17, Num 1, pp 46-47, issn 0538-4818Article

Decreased platelet sensitivity to prostacyclin (epoprostenol) during hemodialysisKRISTENSEN, S. D; KNUDSEN, F; NIELSEN, A. H et al.Clinical nephrology. 1984, Vol 21, Num 4, pp 230-234, issn 0301-0430Article